Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases
Liquid biopsy profiling of circulating tumor DNA (ctDNA) has become established as a compelling, pragmatic diagnostic in the care of cancer patients and is now endorsed by multiple cancer care guidelines. Moreover, ctDNA profiling technologies have advanced significantly and offer increasingly compr...
Saved in:
| Main Authors: | Aakash Desai, Lincoln W. Pasquina, Candice Nulsen, Rachel B. Keller-Evans, Douglas A. Mata, Hanna Tukachinsky, Geoffrey R. Oxnard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | The Journal of Liquid Biopsy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950195424000055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
by: Saori Mishima, et al.
Published: (2023-09-01) -
Circulating tumor DNA (ctDNA) Detection via electrochemical Biosensing Tools
by: Sonya Sahin, et al.
Published: (2024-06-01) -
Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2023-12-01) -
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01) -
Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
by: Yidong Zhou, et al.
Published: (2019-05-01)